Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Need immediate cash? Explore where to sell things for immediate cash and get the funds you need right away.
20,928 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Tesla sits near the $400 mark as investors weigh future growth against current prices. This guide helps you decide wh...
A mom of four faced big financial odds when her spouse traveled for work. This story explains how she built a 4-renta...
In 2026, investors are focusing on profits, not just sales. This guide explains the walmart metric watch 2026 framewo...
Oil prices slid sharply today, but conocophillips stock dropped today only modestly. This guide explains what drove C...
Oil has crossed the $100 mark, creating income opportunities in energy. Here are two no-brainer energy dividend stock...
When evaluating telecom stocks, investors ask which is the better telecom stock: verizon versus Rogers. This guide br...
In 2026, savvy investors favor dividend stocks that reliably pay and grow. This article highlights two no-brainer div...
Real estate cycles linger, but today’s price pressures aren’t a carbon copy of 2008. Learn how Ken McElroy analyzes c...
As the first federal reserve inflation forecast for March lands, markets wrestle with what it signals for rate paths ...
A surge in AI workloads hinges on memory, and Micron’s latest signals hint at lasting strength. This piece unpacks wh...
A fresh wave of legal headlines rattled the markets, pulling down a big‑name hardware stock and lifting caution acros...